EUVIMEDEUVIMED entdecken
Crossref

Diagnosis, treatment and prognosis of patients with small bowel adenocarcinoma in Landspítali University Hospital 2002-2021

Silja Dogg Helgadottir, Karin Ulrika Johansen, Kristin Huld Haraldsdottir

Laeknabladid · 10.06.2026 · 112 (06) · 270-275

DOI: 10.17992/lbl.2026.06.896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laeknabladid, online erschienen am 10.06.2026. Verfasst von Silja Dogg Helgadottir und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of medicine, University of Iceland. Hauptthemen laut MEDLINE: Adenocarcinoma, Duodenal Neoplasms, Intestine, Small, Intestinal Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Small intestine adenocarcinoma is a rare cancer with poor prognosis. The only curative treatment is surgery to remove the tumor. If the tumor is located in the duodenum, a pancreaticoduodenectomy is recommended, while partial resection of the small intestine is advised for tumors located more distally. Materials and methods: Data was obtained from the medical records system at Landspítali. Variables were recorded in Excel, and descriptive statistics along with survival calculations were performed using the statistical software R.

Results

A total of 47 patients were diagnosed with small intestine adenocarcinoma, 32 in the duodenum and 15 more distally. Curative surgery was performed on 25 patients. Severe complications (≥3 on the Clavien-Dindo scale) occurred in 32% of cases. The recurrence rate was 24%. One-year survival for patients undergoing surgery was 80%, while five-year survival rate was 56%. Five-year survival was higher for tumors originating in the duodenum (70,6%) compared to other parts of the small intestine (25,0% p>0,05).

Conclusion

Small intestine adenocarcinoma is a rare condition, with few patients diagnosed during the study period. A high proportion of patients underwent surgery, but one out of every four was diagnosed with recurrence during follow-up. No previous results for small intestine cancer in Iceland have been published, making comparisons with other countries difficult due to the low incidence of this cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaDuodenal NeoplasmsIntestine, SmallIntestinal NeoplasmsHumansFemaleTreatment OutcomeTime FactorsMaleNeoplasm Recurrence, LocalAgedHospitals, UniversityMiddle AgedIcelandPancreaticoduodenectomyRisk FactorsAged, 80 and overRetrospective StudiesAdult

Stichwörter der Autor:innen

AdenocarcinomaDuodenal cancerWhipple operationadenocarcinoma of the small bowelbowel resectionsmall bowel carcinoma

Autor:innen und Institutionen

  • Department of medicine, University of Iceland.
  • Department of abdominal surgery Landspitali University hospital, Department of Biomedical and Clinical Sciences, Linköping University, Sweden, Clinical Department of Surgery in Linköping, Region Östergötland, Linköping,…
  • Department of medicine, University of Iceland, Department of abdominal surgery Landspitali University hospital.

Zitieren

APA

Helgadottir, S. D., Johansen, K. U., & Haraldsdottir, K. H. (2026). Diagnosis, treatment and prognosis of patients with small bowel adenocarcinoma in Landspítali University Hospital 2002-2021. Laeknabladid, 112(06), 270-275. https://doi.org/10.17992/lbl.2026.06.896

Vancouver

Helgadottir SD, Johansen KU, Haraldsdottir KH. Diagnosis, treatment and prognosis of patients with small bowel adenocarcinoma in Landspítali University Hospital 2002-2021. Laeknabladid. 2026;112(06):270-275. doi:10.17992/lbl.2026.06.896

BibTeX
@article{Helgadottir2026,
  author = {Helgadottir, Silja Dogg and Johansen, Karin Ulrika and Haraldsdottir, Kristin Huld},
  title = {Diagnosis, treatment and prognosis of patients with small bowel adenocarcinoma in Landspítali University Hospital 2002-2021},
  journal = {Laeknabladid},
  year = {2026},
  volume = {112},
  number = {06},
  pages = {270--275},
  doi = {10.17992/lbl.2026.06.896}
}
Kostenlos starten →